About the Sponsor

St. Jude Medical Neuromodulation Division is the company sponsoring the BROADEN clinical study. It is a division of St. Jude Medical, a manufacturer of cardiac pacemakers, implantable defibrillators, heart valves, and neurostimulation devices. Over one million mothers, fathers, grandparents, and children worldwide have received a life-saving St. Jude Medical device. To learn more about St. Jude Medical, visit www.sjm.com.

St. Jude Medical Neuromodulation is a technology leader in implantable neurostimulation therapies, with 30 years of experience, numerous technological firsts, and multiple awards for excellence in product design and business. More than 60,000 patients in over 35 countries have been implanted with St. Jude Medical neurostimulation systems. St. Jude Medical Neuromodulation Division’s goal is to improve the lives of the millions of people around the world who suffer with disabling pain or nervous system disorders. To learn more about St. Jude Medical Neuromodulation Division, visit www.sjmneuro.com.